First Time Loading...

BiVictriX Therapeutics PLC
LSE:BVX

Watchlist Manager
BiVictriX Therapeutics PLC Logo
BiVictriX Therapeutics PLC
LSE:BVX
Watchlist
Price: 12 GBX 4.35%
Updated: May 7, 2024

BiVictriX Therapeutics PLC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BiVictriX Therapeutics PLC
Cash from Operating Activities Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
BiVictriX Therapeutics PLC
LSE:BVX
Cash from Operating Activities
-£2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Operating Activities
-$160.3m
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Operating Activities
-$145.6m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Operating Activities
-$60.6m
CAGR 3-Years
-5%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Operating Activities
£2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Operating Activities
£44.6m
CAGR 3-Years
-16%
CAGR 5-Years
4%
CAGR 10-Years
3%

See Also

What is BiVictriX Therapeutics PLC's Cash from Operating Activities?
Cash from Operating Activities
-2.4m GBP

Based on the financial report for Dec 31, 2022, BiVictriX Therapeutics PLC's Cash from Operating Activities amounts to -2.4m GBP.

What is BiVictriX Therapeutics PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
-34%

Over the last year, the Cash from Operating Activities growth was -34%.